The capacity to precipitate quantitatively with homologous antiserum of native protoplasmic polysaccharide from Escherichia coli was not reduced by incubation in human plasma; it was reduced with the immunochemically related lipopolysaccharide.
During the alteration of endotoxin by plasma it has been hypothesized that the lipopolysaccharide (LPS) element was dissociated into subunits which were then bound by plasma proteins (6) . The end result was a biologically and immunologically inactive preparation of LPS (6, 8) .
The protoplasms of certain strains of Escherichia coli have been shown to contain a nontoxic native protoplasmic polysaccharide (NPP) which was related immunochemically to the LPS extractable from homologous cell walls (1, 2) . During studies on the molecular nature of the endotoxin-altering reaction, attempts were made to alter the immunochemical structure of NPP by incubation in human plasma. Results of these studies, presented below, indicated that NPP was not susceptible to alteration by human plasma.
Escherichia coli 0113 (Braude strain) was grown in M-9 medium containing 0.5% glucose as described previously (3) . The cells were disrupted in a refrigerated cell fractionator and the protplasm was separated from the cell walls. LPS was extracted from the cell walls by the phenol-water procedure (10), and NPP was extracted from the protoplasm with cold trichloroacetic acid (2) . Antisera were obtained from rabbits which had been inoculated repeatedly over several months with heat-killed suspensions of the homologous bacteria.
The NPP and LPS were incubated for 4 h at 37 C with citrated human plasma or in phosphate-buffered saline. This was the same protocol which had been used routinely for the alteration of endotoxin (8) .
The capacity of LPS and NPP to be precipitated quantitatively by homologous antiserum was determined as described previously (9) .
The results of these studies are summarized in Fig. 1 did not reduce the capacity of NPP to be precipitated by homologous antiserum (Fig. 1) , whereas incubation of LPS with human plasma reduced greatly its quantitative precipitation with antiserum (Fig. 2) . Similar results have been obtained with NPP preparations from E.
INFECT. IMMUNITY coli 026:B6 and E. coli 055:B5. These data indicated that the endotoxin-altering factors of human plasma were not reacting with NPP.
The results are open to several interpretations. NPP has been shown to be simple molecules (7), not possessing a quaternary structure of subunits like LPS molecules (5). Thus, dissociation of NPP molecules would not occur during incubation in plasma and this might have interrupted the endotoxin-altering reaction. An additional explanation for the lack of reactivity of NPP and human plasma might be found in the primary chemical structure of NPP. Whereas endotoxic LPS molecules contained esterified long-chain fatty acids in the lipid portion of the molecule (4), the ester bonds in NPP were formed by acetyl residues (1). Furthermore, the NPP contained only trace amounts of heptose and 2-keto-3-deoxyoctulosonate (1) . If lipid or the core portions of LPS were the sites of binding by plasma proteins during the endotoxin-altering reaction, this could explain why NPP cannot be altered by incubation in human plasma.
